HR6296

The Advancing Access to Telehealth Act permanently extends Medicare telehealth flexibilities, including allowing rural health clinics and federally qualified health centers to serve as distant sites, beneficiaries' homes to serve as originating sites for all services, and audiologists, physical therapists, occupational therapists, and speech-language pathologists to furnish telehealth services. This eliminates the sunset risk associated with temporary COVID-19 emergency measures, providing long-term revenue visibility for companies operating in the telehealth space. The bill directly amends Medicare regulations, ensuring these services are covered on an ongoing basis. This legislation does not appropriate new funds but rather redefines the scope of services covered under existing Medicare budgets. The money trail flows directly from Medicare reimbursements to telehealth providers and diagnostic service companies. Companies offering virtual care platforms and remote diagnostic solutions are positioned to capture this expanded market. The mechanism is regulatory relief, ensuring that services previously covered temporarily are now permanently reimbursable, thereby incentivizing investment and expansion in these areas. Historically, the expansion of Medicare coverage for new service types has led to increased utilization and revenue for providers. For example, when Medicare Part D was implemented in 2006, pharmaceutical companies and pharmacies saw a significant and sustained increase in prescription drug sales and dispensing volumes. While not a direct comparison in terms of scale, the permanent nature of this telehealth expansion mirrors the long-term impact of such policy changes. During the initial COVID-19 telehealth expansion in March 2020, telehealth providers like Teladoc Health ($TDOC) saw their stock price surge over 100% in the following three months, demonstrating the market's positive reaction to increased access and utilization. Specific winners include virtual care platform providers such as Teladoc Health ($TDOC), Amwell ($AMWL), and One Medical (part of Amazon, $AMZN). Diagnostic service providers that can integrate remote diagnostics or benefit from increased telehealth consultations leading to diagnostic orders, such as LabCorp ($LH) and Quest Diagnostics ($DGX), also stand to gain. There are no clear losers from this expansion, as it broadens access without restricting existing services. The bill has been referred to two committees, indicating it will undergo committee review before potentially moving to a floor vote. Rep. Dingell, a Democrat from Michigan, is the sponsor, and the bill has one cosponsor, suggesting moderate but not overwhelming initial legislative momentum. What happens next is committee consideration. Given the permanent nature of the changes, the market will likely price in the long-term benefits as the bill progresses through Congress. If it passes, the impact will be felt immediately upon enactment, as providers will have certainty regarding reimbursement for these expanded services.